Target intelligence / Profile preview

Protein synthesis machinery via Pseudomonas exotoxin-mediated inhibition

Molecular classification
Process, Toxin-mediated inhibition
01

Overview

The cellular process of protein synthesis that is specifically disrupted by the action of Pseudomonas Exotoxin A (PE), a potent bacterial toxin produced by *Pseudomonas aeruginosa*. PE exerts its cytotoxic effect by irreversibly inhibiting eukaryotic protein synthesis, ultimately leading to cell death. PE enters target cells through receptor-mediated endocytosis, undergoes intracellular trafficking to the ER, translocates to the cytosol, and catalyzes ADP-ribosylation of elongation factor 2 (EF-2), an essential component for ribosomal translocation during mRNA translation. This modification inactivates EF-2, halting protein synthesis and triggering cell death. While PE itself is not a therapeutic target, the process of inhibiting protein synthesis by PE is relevant in the context of understanding bacterial pathogenesis and developing targeted therapies that exploit this mechanism.

Other names
Pseudomonas Exotoxin A mediated protein synthesis inhibitionPE-mediated protein synthesis inhibitionElongation Factor 2 ADP-ribosylation by Pseudomonas Exotoxin A
02

Mechanism of action

ADP-ribosylation and inactivation of Elongation Factor 2 (EF-2)

03

Biological functions

Protein synthesis inhibitionCell death inductionHost-pathogen interaction
04

Disease associations

InfectionCancer (as a therapeutic strategy)
05

Safety considerations

Off-target toxicity of Pseudomonas Exotoxin AImmunogenicity of Pseudomonas Exotoxin ADevelopment of resistance to PE-based therapies
06

Interacting drugs

Pseudomonas Exotoxin A

1 more in the full profile.

Beyond the preview

Go deeper on Protein synthesis machinery via Pseudomonas exotoxin-mediated inhibition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein synthesis machinery via Pseudomonas exotoxin-mediated inhibition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call